Health analytics provider GNS has attracted Celgene, Cambia Health, Mitsui and Heritage Provider Network to its series C round, increasing its total funding to nearly $35m.
US-based healthcare analytics provider GNS Healthcare closed a $10m series C round yesterday backed by a consortium including drug developer Celgene and Mitsui USA, a subsidiary of Japan-based conglomerate Mitsui.
Healthcare services conglomerate Cambia Health Solutions, healthcare provider Heritage Provider Network, real estate manager Alexandria Real Estate Equities and Gi Global Health Fund also contributed to the round.
Founded in 2000, GNS’s technology relies on machine learning to analyse patient data such as electronic medical records, genomics and pharmacy claims…
